Malaria continues to be a global health threat, with approximately 247 million cases
worldwide. Despite therapeutic interventions being available, patient compliance is a …

We investigate thiazolyl-pyrazoline derivatives as promising drugs for the anti-malarial.
Protein kinase G is a primary target for treating malaria due to its essential role in …

Malaria continues to pose a significant global health threat, and the emergence of drug-
resistant malaria exacerbates the challenge, underscoring the urgent need for new …

Malaria is a disease caused by the Plasmodium falciparum parasite and leads to many
cases of deaths. Recently, the combination of several drugs has been used to treat this …

Malaria is a dangerous endemic disease that infects millions yearly. The Plasmodium
falciparum species are responsible for most malaria deaths. Currently, most available …

Cancer is a disease that occurs due to the uncontrolled growth of abnormal cells causing
body tissue damage. This disease is considered as a deadly disease. In 2019, 1700 deaths …

Diabetes mellitus is a chronic disease that can occur in anyone. Up until now, there are no
specific drugs have been found which can completely cure diabetes. One of the possible …

Dementia is a fast-growing public health problem, with an estimated 47 million people
currently living with the condition. By 2030, this total is predicted to reach 75 million. By …

Aedes aegypti is one of the most dangerous mosquitoes that can cause several deadly
diseases, such as dengue fever, Chikungunya, Zika, and jaundice with high mortality rate …

Quantitative structure–activity relationship studies conducted on forty-five (45) derivatives of
2-anilino 4-amino substituted quinazolines as malaria inhibitors to determine the structures …